LENSAR, Inc. develops and markets robotic laser systems for cataract treatment and astigmatism management. The company’s product portfolio includes the ALLY Robotic Cataract Laser System, the LENSAR Laser System with Streamline IV and IntelliAxis, related software, and associated consumable components.
Recurring company updates focus on ALLY system placements, installed-base activity, procedure volume, and recurring revenue from procedure, lease, and service sources. LENSAR news also includes quarterly and annual results, medical-device regulatory disclosures, material agreements, capital-structure matters, and governance actions such as equity inducement awards.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.